Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abroad, adenoviral, AntibioticsTM, ASU, bandage, billion, blockage, burst, chemical, chronic, chronically, cord, crossed, crystalline, cured, dealer, Delaware, developmental, diabetic, disposition, distinct, division, easier, encrustation, flat, floating, flushing, foot, France, gel, half, harbor, Honk, impractical, irrigation, irritancy, IRS, Japanese, jointly, killer, lifetime, long, margin, microbiological, mitigation, mixture, mode, moistening, move, Moving, mupirocin, Muranishi, neurology, NOL, Obama, occurrence, Odenberg, ophthalmology, opposed, oxidative, parallel, partnership, passage, pathogen, perpetual, physiologically, pilot, population, predetermined, pressure, profile, programatic, propensity, quantitative, randomized, recoverability, redirection, reform, Reincorporation, serial, serving, slowly, spinal, stake, standpoint, superbug, superficial, susceptible, Switzerland, territory, top, transparency, UCBE, ulcer, Ullakko, unamortized, underserved, undiscounted, unlimited, urology, User, vendor, versatility, Wall
Removed:
agent, APB, attached, attestation, authority, automatically, call, cleanser, close, collectibility, comparative, converted, convertible, customary, denominator, EITF, exhibit, expanding, forma, forward, greatly, hospitalization, Intercompany, introduced, involvement, lavage, line, memo, modified, molecule, nasal, numerator, occurring, permit, placement, prepaid, pro, promissory, recently, repayment, reservoir, retail, reverse, safer, separately, shareholder, short, show, speed, split, stabilize, superseded, therapy, trademarked, usable, vested, wholesaler, wholly
Filing tables
Filing exhibits
- 10-K Annual report
- 10.24 Amendment No. 2 to the Collaboration and License Agreement, Dated As of December 2, 2010, Between the Company and Galderma S.a.
- 10.25 Amendment No. 1 to the Collaboration and License Agreement Dated November 18, 2010 by and Between the Company and Alcon Manufacturing, LTD.
- 23.1 Consent of Odenberg, Ullakko, Muranishi & Co. LLP
- 23.2 Consent of Davidson & Co, LLP
- 31.1 Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 23.1 Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 23.2 Certification of the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
NBY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on S-8 (333-147334, 333-157041, 333-164469, and 333-171981) and on Form S-3 (333-159917) of our report dated March 7, 2011, with respect to the consolidated financial statements of NovaBay Pharmaceuticals, Inc. included in its Annual Report on Form 10-K for the year ended December 31, 2010.
/S/ Odenberg, Ullakko, Muranishi & Co. LLP
San Francisco, CA
March 7, 2011